Showing results (1051-1060 of 1,523) with videos related to

Sort By:
Pageof 153
Future Oncology (London, England)|December 14, 2023
HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced <i>EGFR</i>-mutated NSCLC after a third-generation EGFR TKITony Mok, Pasi A Jänne, Makoto Nishio, et al.
JTO Clinical and Research Reports|September 15, 2020
Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People's Republic of ChinaRui Fu, Lin Wu, Chao Zhang, et al.
BMJ Open|March 8, 2023
Lipid management in ischaemic stroke or transient ischaemic attack in China: result from China National Stroke Registry IIIYu-Yuan Xu, Wei-Qi Chen, Meng-Xing Wang, et al.
Angewandte Chemie (International Ed. in English)|March 16, 2026
Trace Capture Hexafluoropropylene From Octafluoropropane via Complete Molecular Sieving Mechanism in a Highly Robust Metal-Organic FrameworkLan Lan, Si-Jia Wei, Wei Xia, et al.
Stroke|April 23, 2019
Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and DeathXiao-Meng Yang, Zhen-Zhen Rao, Hong-Qiu Gu, et al.
Science Advances|November 14, 2025
Hepatic hypertension on-a-chip identifies GPR116 as a hydrostatic pressure mechanosensor to regulate vascular injury in cirrhosisYi Long, Kaini Liang, Yudi Niu, et al.
European Radiology|December 12, 2024
Noninvasive identification of proliferative hepatocellular carcinoma on multiphase dynamic CT: quantitative and LI-RADS lexicon-based evaluationWanli Zhang, Nan Li, Jiamin Li, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Preexisting Heart Disease Spectrum and In-Hospital Outcomes for Patients With Acute Ischemic StrokeHong-Qiu Gu, Kai-Xuan Yang, Xing-Quan Zhao, et al.
Ebiomedicine|May 16, 2022
Association between high-sensitivity C-reactive protein, functional disability, and stroke recurrence in patients with acute ischaemic stroke: A mediation analysisHong-Qiu Gu, Kai-Xuan Yang, Jin-Xi Lin, et al.
Pharmacoeconomics - Open|February 22, 2023
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung CancerAndre Verhoek, Parneet Cheema, Barbara Melosky, et al.
Pageof 153